Novel therapies for children with acute myeloid leukaemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2013106.pdf
Reference125 articles.
1. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM . Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood 2012; 119: 34–43.
2. Burnett A, Wetzler M, Lowenberg B . Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011; 29: 487–494.
3. Gibson BE, Webb DK, Howman AJ, De Graaf SS, Harrison CJ, Wheatley K . Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial. Br J Haematol 2011; 155: 366–376.
4. Pui CH, Carroll WL, Meshinchi S, Arceci RJ . Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update. J Clin Oncol 2011; 29: 551–565.
5. Creutzig U, van den Heuvel-Eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel, on behalf of the AML Committee of the International BFM Study Group. Blood 2012; 120: 3187–3205.
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group;PROTEOMICS – Clinical Applications;2023-06-07
2. A clinical report on high‑dose cytarabine therapy for children with acute myeloid leukemia;Molecular and Clinical Oncology;2022-10-06
3. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma;European Journal of Cancer;2022-03
4. Immunotherapy Associated Neurotoxicity in Pediatric Oncology;Frontiers in Oncology;2022-02-21
5. Distinct noncoding RNAs and RNA binding proteins associated with high‐risk pediatric and adult acute myeloid leukemia s detected by regulatory network analysis;Cancer Reports;2021-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3